Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/40101
metadata.artigo.dc.title: The epidemiology, diagnosis and treatment of COVID-19
metadata.artigo.dc.creator: Zhai, Pan
Ding, Yanbing
Wu, Xia
Long, Junke
Zhong, Yanjun
Li, Yiming
metadata.artigo.dc.subject: COVID-19 - Pandemic
COVID-19 - Diagnosis
COVID-19 - Isolation
Remdesivir
Clinical trials
metadata.artigo.dc.publisher: Elsevier
metadata.artigo.dc.date.issued: Mar-2020
metadata.artigo.dc.identifier.citation: ZHAI, P. et al. The epidemiology, diagnosis and treatment of COVID-19. International Journal of Antimicrobial Agents, [S.l.], Mar. 2020.
metadata.artigo.dc.description.abstract: In December 2019, the outbreak of the novel coronavirus disease (COVID-19) in China spread worldwide, becoming an emergency of major international concern. SARS-CoV-2 infection causes clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus. Human-to-human transmission via droplets, contaminated hands or surfaces has been described, with incubation times of 2-14 days. Early diagnosis, quarantine, and supportive treatments are essential to cure patients. This paper reviews the literature on all available information about the epidemiology, diagnosis, isolation and treatments of COVID-19. Treatments, including antiviral agents, chloroquine and hydroxychloroquine, corticosteroids, antibodies, convalescent plasma transfusion and vaccines, are discussed in this article. In addition, registered trials investigating treatment options for COVID-19 infection are listed.
metadata.artigo.dc.identifier.uri: https://www.sciencedirect.com/science/article/pii/S0924857920301059
http://repositorio.ufla.br/jspui/handle/1/40101
metadata.artigo.dc.language: en_US
Appears in Collections:FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.